Stocks Analysis by The Tokenist (Timothy Fries) covering: Immunitybio Inc. Read The Tokenist (Timothy Fries)'s latest article on Investing.com
Biotech stocks, especially of smaller companies, are notoriously risky investment exposures. Because their bread and butter is drug development, its complexity cannot be easily accounted for.
In combination with ImmunityBio’s Bacillus Calmette-Guérin vaccine, Anktiva is set to treat non-muscle invasive bladder cancer from mid-May. For investors, bladder cancer is fairly common, at an average rate of 18.2 per 100,000, with 75-80% of newly diagnosed cases classified as NMBIC. However, operating expense losses decreased from $111.9 million to $95.2 million during the period. ImmunityBio left the quarter with $133.3 million in cash, cash equivalents, and restricted cash .
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
3 Smaller Tech Stocks to Buy as Focus Shifts From MegacapsStocks Analysis by The Tokenist (Timothy Fries) covering: S&P 500, Intel Corporation, NVIDIA Corporation, Advanced Micro Devices Inc. Read The Tokenist (Timothy Fries)'s latest article on Investing.com
Read more »
3 Small-Cap AI Stocks With Serious Growth PotentialStocks Analysis by The Tokenist (Timothy Fries) covering: S&P 500, NVIDIA Corporation, Advanced Micro Devices Inc, Innodata Inc. Read The Tokenist (Timothy Fries)'s latest article on Investing.com
Read more »
Bitcoin: Analyzing the Recent Price Dip to $57k and Future OutlookMarket Analysis by The Tokenist (Timothy Fries) covering: Bitcoin. Read The Tokenist (Timothy Fries)'s Market Analysis on Investing.com
Read more »
Apple Leads the US Buyback Resurgence, but Is it Sustainable?Stocks Analysis by The Tokenist (Timothy Fries) covering: Chevron Corp, Apple Inc, Samsung Electronics Co Ltd, Xiaomi Corp. Read The Tokenist (Timothy Fries)'s latest article on Investing.com
Read more »
Tesla: Critical 2-Year Horizon Will Make or Break ItStocks Analysis by The Tokenist (Timothy Fries) covering: Nasdaq 100, Tesla Inc, Nio Inc Class A ADR, Li Auto Inc. Read The Tokenist (Timothy Fries)'s latest article on Investing.com
Read more »
Intel: A Buying Opportunity or a Lost Cause?Stocks Analysis by The Tokenist (Timothy Fries) covering: Intel Corporation, Dell Technologies Inc, Qualcomm Incorporated, Apple Inc. Read The Tokenist (Timothy Fries)'s latest article on Investing.com
Read more »